SunTrust Robinson Humphrey Initiates Sage Therapeutics At Buy By: Benzinga via Benzinga January 27, 2015 at 08:02 AM EST Analysts at SunTrust Robinson Humphrey initiated coverage on Sage Therapeutics, Inc. (NASDAQ: SAGE) with a Buy rating. The target ... Read More >> Related Stocks: Sage Therapeutic Com